These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes. Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097 [TBL] [Abstract][Full Text] [Related]
6. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R). Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144 [TBL] [Abstract][Full Text] [Related]
7. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists. Froimowitz M; Cody V Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550 [TBL] [Abstract][Full Text] [Related]
8. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor. Schwalbe T; Kaindl J; Hübner H; Gmeiner P Bioorg Med Chem; 2017 Oct; 25(19):5084-5094. PubMed ID: 28666858 [TBL] [Abstract][Full Text] [Related]
9. 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation. Möller D; Salama I; Kling RC; Hübner H; Gmeiner P Bioorg Med Chem; 2015 Sep; 23(18):6195-209. PubMed ID: 26299826 [TBL] [Abstract][Full Text] [Related]
10. Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures. Tomlinson ID; Kovtun O; Crescentini TM; Rosenthal SJ Bioorg Med Chem Lett; 2019 Apr; 29(8):959-964. PubMed ID: 30808590 [TBL] [Abstract][Full Text] [Related]
11. Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole. Klein Herenbrink C; Verma R; Lim HD; Kopinathan A; Keen A; Shonberg J; Draper-Joyce CJ; Scammells PJ; Christopoulos A; Javitch JA; Capuano B; Shi L; Lane JR ACS Chem Biol; 2019 Aug; 14(8):1780-1792. PubMed ID: 31339684 [TBL] [Abstract][Full Text] [Related]
12. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density. Lian J; Huang XF; Pai N; Deng C Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047 [TBL] [Abstract][Full Text] [Related]
14. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding. Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624 [TBL] [Abstract][Full Text] [Related]
15. The Universal 3D QSAR Model for Dopamine D Zięba A; Żuk J; Bartuzi D; Matosiuk D; Poso A; Kaczor AA Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540025 [TBL] [Abstract][Full Text] [Related]
16. Docking Screens of Noncovalent Interaction Motifs of the Human Subtype-D2 Receptor-75 Schizophrenia Antipsychotic Complexes with Physicochemical Appraisal of Antipsychotics. Amani P; Habibpour R; Karami L; Hofmann A ACS Chem Neurosci; 2021 Jun; 12(12):2218-2232. PubMed ID: 34061513 [TBL] [Abstract][Full Text] [Related]
17. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Wang S; Che T; Levit A; Shoichet BK; Wacker D; Roth BL Nature; 2018 Mar; 555(7695):269-273. PubMed ID: 29466326 [TBL] [Abstract][Full Text] [Related]